Medical Imaging

Neko Health has secured $700 million in Series C funding, enabling its expansion into the U.S. market with AI-powered preventive health screenings. The company combines advanced imaging, blood tests, sensor technology, and clinician review to detect early health indicators. It plans to launch its first U.S. clinic in New York City. This substantial investment, led by Lightspeed Venture Partners, underscores investor confidence in Neko’s proactive healthcare approach.